EMRTICKER
Emerson Electric Co.
Congress has disclosed 45 buys and 29 sells of EMR (Emerson Electric Co.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
45
Buy
29
Sell
+16
Net
28
Active politicians
Round-trip watch Still on the books
Members who disclosed buying EMR and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Bruce Westerman | 2025-03-03 | $114.40 | $164.94 | +44.2% | in profit |
| Alan Armstrong | 2026-03-27 | $124.47 | $164.94 | +32.5% | in profit |
| Richard Dean McCormick | 2025-11-05 | $130.40 | $164.94 | +26.5% | in profit |
| Rohit Khanna | 2026-04-13 | $143.39 | $164.94 | +15.0% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Price & congressional trades
Buy
Sell
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Industrials. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
P/E
35.69
▲ pricier than
Industrials (median 24.6)
how it's calculated
P/E = price ÷ earnings per share
$164.94 ÷ $4.62 = 35.69
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
4.51
≈ in line with
Industrials (median 4.4)
how it's calculated
P/B = price ÷ book value per share
$164.94 ÷ $36.53 = 4.51
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
74 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Kevin Hern | House | SELL ◆ insider convergence | Joint · Hern Family Revocable Trust | 2026-09-14 | 1 days | -0.9% | $1K–$15K 0.1% of NW |
49.6 | ↗ filing |
| Richard Dean McCormick | House | SELL ◆ insider convergence · moderate | Self · Growth Partners Roth IRA | 2026-07-30 | 13 days | +10.2% | $1K–$15K 0.7% of NW |
48.9 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Spouse | 2026-04-13 | 21 days | -6.2% | $1K–$15K | 47.4 | ↗ filing |
| Alan Armstrong | Senate | BUY ◆ insider divergence · moderate | Self | 2026-03-27 | 116 days | +11.5% | $1K–$15K | 89.2 | ↗ eFD |
| Richard Dean McCormick | House | BUY ◆ insider divergence | Self | 2025-11-05 | 34 days | +2.6% | $1K–$15K 0.7% of NW |
30.1 | ↗ filing |
| Valerie Hoyle | House | SELL | Spouse · Fidelity Rollover IRA | 2025-09-23 | 0 days | 0.0% | $1K–$15K 0.8% of NW |
30.3 | ↗ filing |
| Valerie Hoyle | House | BUY | Spouse · Fidelity Rollover IRA | 2025-07-14 | 59 days | -1.3% | $1K–$15K 0.8% of NW |
65.7 | ↗ filing |
| Ritchie John Torres | House | SELL ◆ insider convergence | Self | 2025-07-11 | 21 days | +1.2% | $1K–$15K 3.2% of NW 🔥 |
85.0 | ↗ filing |
| Rob Bresnahan | House | SELL ◆ insider convergence · moderate | Self · JP Morgan Brokerage Account | 2025-04-08 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
33.6 | ↗ filing |
| Lisa McClain | House | SELL ◆ insider convergence · moderate | Spouse · Charles Schwab Brokerage Account 548 | 2025-03-12 | 154 days | +22.3% | $1K–$15K 0.1% of NW |
33.3 | ↗ filing |
| Bruce Westerman | House | BUY ◆ insider divergence | Self · Fisher IRA | 2025-03-03 | 14 days | -3.1% | $1K–$15K 0.7% of NW |
84.8 | ↗ filing |
| Rob Bresnahan | House | BUY ◆ insider divergence | Self · JP Morgan Brokerage Account | 2025-02-25 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
82.6 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence | Spouse · Charles Schwab Brokerage Account 548 | 2025-02-05 | 189 days | +9.1% | $1K–$15K 0.1% of NW |
82.5 | ↗ filing |
| Kevin Hern | House | BUY | Joint · Hern Family Revocable Trust > Brokerage Investment Account | 2024-06-10 | 1 days | — | $1K–$15K 0.1% of NW |
0.4 | ↗ filing |
| Kevin Hern | House | BUY ◆ insider divergence · moderate | Joint · Hern Family Revocable Trust > Brokerage Investment Account | 2024-03-11 | 1 days | — | $1K–$15K 0.1% of NW |
0.4 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · strong | Child | 2024-01-10 | 23 days | — | $1K–$15K | 52.4 | ↗ filing |
| Kevin Hern | House | BUY ◆ insider convergence · strong | Joint · Hern Family Revocable Trust > Brokerage Investment Account | 2023-12-11 | 1 days | — | $1K–$15K 0.1% of NW |
12.3 | ↗ filing |
| John Curtis | House | SELL ◆ insider divergence · strong | Joint · Northwestern Mutual - Joint | 2023-12-04 | 0 days | — | $1K–$15K | 40.4 | ↗ filing |
| John Curtis | House | BUY ◆ insider convergence · strong | Joint · Northwestern Mutual - Joint | 2023-09-13 | 19 days | — | $1K–$15K | 86.8 | ↗ filing |
| Kevin Hern | House | BUY ◆ insider convergence · strong | Joint · Hern Family Revocable Trust > Brokerage Investment Account | 2023-09-11 | 1 days | — | $1K–$15K 0.1% of NW |
12.3 | ↗ filing |
| Kevin Hern | House | BUY ◆ insider divergence | Joint · Hern Family Revocable Trust > Brokerage Investment Account | 2023-06-09 | 3 days | — | $1K–$15K 0.1% of NW |
2.6 | ↗ filing |
| Zoe Lofgren | House | SELL ◆ insider convergence | Spouse · John Marshall Collins Rollover IRA | 2023-05-25 | 12 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Rohit Khanna | House | BUY OCR | Child | 2023-03-24 | 10 days | — | $1K–$15K | 93.1 | ↗ filing |
| Richard Dean McCormick | House | BUY | Self · Growth Partners Roth IRA | 2023-03-15 | 26 days | — | $1K–$15K 0.7% of NW |
93.1 | ↗ filing |
| Kevin Hern | House | BUY | Joint · Hern Family Revocable Trust > Brokerage Investment Account | 2023-03-10 | 3 days | — | $1K–$15K 0.1% of NW |
25.2 | ↗ filing |
| Kevin Hern | House | BUY | Joint · Hern Family Revocable Trust > Brokerage Investment Account | 2022-12-09 | 3 days | — | $1K–$15K 0.1% of NW |
5.5 | ↗ filing |
| Earl Blumenauer | House | BUY | Spouse | 2022-09-26 | 9 days | — | $1K–$15K 0.1% of NW |
86.8 | ↗ filing |
| Kevin Hern | House | BUY | Joint · Hern Family Revocable Trust > Brokerage Investment Account | 2022-09-09 | 1 days | — | $1K–$15K 0.1% of NW |
17.4 | ↗ filing |
| Carol Devine Miller | House | SELL | Spouse | 2022-08-08 | 24 days | — | $15K–$50K 0.1% of NW |
90.9 | ↗ filing |
| Kevin Hern | House | BUY | Joint · Hern Family Revocable Trust > Brokerage Investment Account | 2022-06-10 | 1 days | — | $1K–$15K 0.1% of NW |
8.6 | ↗ filing |
| Kevin Hern | House | BUY | Joint · Hern Family Revocable Trust > Brokerage Investment Account | 2022-03-10 | 1 days | — | $1K–$15K 0.1% of NW |
10.6 | ↗ filing |
| Kevin Hern | House | BUY | Joint | 2021-12-10 | 1 days | — | $1K–$15K 0.1% of NW |
15.7 | ↗ filing |
| Kevin Hern | House | BUY | Joint | 2021-09-10 | 3 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Kevin Hern | House | BUY | Joint | 2021-07-01 | 1 days | — | $50K–$100K 0.9% of NW |
61.4 | ↗ filing |
| Kevin Hern | House | BUY | Joint | 2021-05-18 | 1 days | — | $250K–$500K 4.5% of NW 🔥 |
97.6 | ↗ filing |
| Peter Meijer | House | SELL | Self | 2021-02-16 | 3 days | — | $1K–$15K | 75.9 | ↗ filing |
| Bob Gibbs | House | BUY | Self | 2020-07-31 | 0 days | — | $1K–$15K | 75.9 | ↗ filing |
| Dean Phillips | House | BUY | Self | 2020-05-13 | 28 days | — | $1K–$15K <0.1% of NW |
19.6 | ↗ filing |
| Michael Conaway | House | BUY | Spouse | 2020-04-22 | 5 days | — | $15K–$50K | 49.8 | ↗ filing |
| Katherine Clark | House | SELL | Spouse | 2020-04-03 | 48 days | — | $1K–$15K 0.1% of NW |
26.5 | ↗ filing |
| Dean Phillips | House | SELL | Self | 2020-04-02 | 34 days | — | $1K–$15K <0.1% of NW |
26.5 | ↗ filing |
| Dean Phillips | House | BUY | Self | 2020-03-17 | 20 days | — | $1K–$15K <0.1% of NW |
22.3 | ↗ filing |
| Dean Phillips | House | BUY | Self | 2020-03-16 | 21 days | — | $1K–$15K <0.1% of NW |
40.4 | ↗ filing |
| David Price | House | BUY | Self | 2019-08-15 | 4 days | — | $1K–$15K | 75.9 | ↗ filing |
| Bill Flores | House | SELL | Self | 2019-03-22 | 12 days | — | $1K–$15K | 2.6 | ↗ filing |
| Dean Phillips | House | SELL | Self | 2019-01-04 | 32 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2018-08-30 | 1 days | — | $1K–$15K | 22.3 | ↗ filing |
| Katherine Clark | House | BUY | Spouse | 2018-01-03 | 36 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Bill Flores | House | SELL | Self | 2017-12-27 | 16 days | — | $1K–$15K | 2.6 | ↗ filing |
| Debbie Dingell | House | BUY | Self | 2017-10-31 | 6 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Bill Flores | House | SELL | Self | 2017-03-24 | 10 days | — | $1K–$15K | 2.6 | ↗ filing |
| Bill Flores | House | SELL | Self | 2017-02-03 | 31 days | — | $1K–$15K | 4.5 | ↗ filing |
| Bill Flores | House | SELL | Self | 2016-12-21 | 15 days | — | $1K–$15K | 5.5 | ↗ filing |
| Bill Flores | House | SELL | Self | 2016-11-29 | 6 days | — | $1K–$15K | 6.8 | ↗ filing |
| Bill Flores | House | BUY | Self | 2016-11-08 | 27 days | — | $1K–$15K | 8.6 | ↗ filing |
| James French Hill | House | BUY | Spouse | 2016-06-13 | 0 days | — | $15K–$50K 0.3% of NW |
94.9 | ↗ filing |
| Thomas Rooney | House | BUY | Self | 2016-06-01 | 30 days | — | $1K–$15K | 86.8 | ↗ filing |
| Bill Flores | House | SELL | Self | 2016-04-18 | 28 days | — | $1K–$15K | 10.6 | ↗ filing |
| Bill Flores | House | SELL | Self | 2016-02-17 | 16 days | — | $1K–$15K | 26.5 | ↗ filing |
| Bill Flores | House | BUY | Self | 2016-01-29 | 6 days | — | $1K–$15K | 22.3 | ↗ filing |
| Richard Hanna | House | SELL | Joint | 2016-01-27 | 20 days | — | $1K–$15K | 86.8 | ↗ filing |
| Bill Flores | House | SELL | Self | 2015-12-29 | 7 days | — | $1K–$15K | 52.4 | ↗ filing |
| Bill Flores | House | BUY | Self | 2015-10-21 | 16 days | — | $15K–$50K | 90.9 | ↗ filing |
| Thomas MacArthur | House | SELL | Child | 2015-01-28 | 4 days | — | $1K–$15K | 22.3 | ↗ filing |
| Thomas MacArthur | House | SELL | Joint | 2015-01-28 | 4 days | — | $100K–$250K | 60.3 | ↗ filing |
| Thomas MacArthur | House | BUY | Child | 2015-01-12 | 20 days | — | $1K–$15K | 40.4 | ↗ filing |
| Thomas MacArthur | House | BUY | Joint | 2015-01-09 | 23 days | — | $15K–$50K | 90.9 | ↗ filing |
| Gary Peters | House | BUY | Self | 2014-11-10 | 0 days | — | $1K–$15K | 82.4 | ↗ filing |
| John Dingell | House | BUY | Self | 2014-09-18 | 4 days | — | $1K–$15K | 92.5 | ↗ filing |
| Katherine Clark | House | SELL | Self | 2014-03-13 | 252 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Katherine Clark | House | SELL | Self | 2014-02-05 | 288 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Michael Conaway | House | BUY | Spouse | 2013-07-26 | 3 days | — | $1K–$15K | 75.9 | ↗ filing |
| Michael Conaway | House | BUY | Spouse | 2013-07-26 | 3 days | — | $1K–$15K | 75.9 | ↗ filing |
| Pete Sessions | House | SELL | Spouse | 2013-04-26 | 0 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in EMR — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
10
Congress trades with insider convergence
9
…with insider divergence
28
Insider open-market trades
Of the congressional trades in EMR, 10 coincided with corporate insiders moving the same way within 60 days, and 9 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-08-11 | Karsanbhai Surendralal Lanca | C-suite | SELL | $1.6M | ↗ EDGAR |
| 2026-08-06 | Train Michael H. | C-suite | SELL | $1.2M | ↗ EDGAR |
| 2026-06-01 | Krishnan Ram R. | C-suite | SELL | $1.6M | ↗ EDGAR |
| 2026-03-10 | Karsanbhai Surendralal Lanca | C-suite | SELL | $811K | ↗ EDGAR |
| 2026-02-10 | LEVATICH MATTHEW S | Director | SELL | $239K | ↗ EDGAR |
| 2026-02-09 | Piazza Nicholas J. | Other | SELL | $1.1M | ↗ EDGAR |
| 2026-02-05 | BLINN MARK A | Director | SELL | $213K | ↗ EDGAR |
| 2026-02-05 | BLINN MARK A | Director | SELL | $226K | ↗ EDGAR |
| 2025-12-03 | Karsanbhai Surendralal Lanca | C-suite | SELL | $966K | ↗ EDGAR |
| 2025-05-12 | Train Michael H. | C-suite | SELL | $3.4M | ↗ EDGAR |
| 2025-05-08 | Karsanbhai Surendralal Lanca | C-suite | SELL | $1.9M | ↗ EDGAR |
| 2025-02-12 | LEVATICH MATTHEW S | Director | SELL | $233K | ↗ EDGAR |
| 2025-02-12 | BLINN MARK A | Director | SELL | $3K | ↗ EDGAR |
| 2025-02-10 | BLINN MARK A | Director | SELL | $235K | ↗ EDGAR |
| 2024-11-13 | Karsanbhai Surendralal Lanca | C-suite | SELL | $6.8M | ↗ EDGAR |
| 2024-11-06 | Train Michael H. | C-suite | SELL | $2.7M | ↗ EDGAR |
| 2024-03-04 | Piazza Nicholas J. | Other | SELL | $239K | ↗ EDGAR |
| 2024-02-15 | LEVATICH MATTHEW S | Director | SELL | $204K | ↗ EDGAR |
| 2024-02-14 | Karsanbhai Surendralal Lanca | C-suite | SELL | $249K | ↗ EDGAR |
| 2024-02-09 | BLINN MARK A | Director | SELL | $249K | ↗ EDGAR |
| 2023-12-15 | Krishnan Ram R. | C-suite | SELL | $1.2M | ↗ EDGAR |
| 2023-11-17 | Karsanbhai Surendralal Lanca | C-suite | BUY | $882K | ↗ EDGAR |
| 2023-11-09 | McKelvey James Morgan Jr. | Director | BUY | $684K | ↗ EDGAR |
| 2023-11-09 | BOLTEN JOSHUA B. | Director | BUY | $43K | ↗ EDGAR |
| 2023-11-08 | GOLDEN ARTHUR F | Director | BUY | $257K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| Congress | 2026-09-14 | Kevin Hern | SELL | $1K–$15K |
| ◆ insider | 2026-08-11 | Karsanbhai Surendralal Lanca C-suite | SELL | $1.6M |
| ◆ insider | 2026-08-06 | Train Michael H. C-suite | SELL | $1.2M |
| Congress | 2026-07-30 | Richard Dean McCormick | SELL | $1K–$15K |
| ◆ insider | 2026-06-01 | Krishnan Ram R. C-suite | SELL | $1.6M |
| Congress | 2026-04-13 | Rohit Khanna | BUY | $1K–$15K |
| Congress | 2026-03-27 | Alan Armstrong | BUY | $1K–$15K |
| ◆ insider | 2026-03-10 | Karsanbhai Surendralal Lanca C-suite | SELL | $811K |
| ◆ insider | 2026-02-10 | LEVATICH MATTHEW S Director | SELL | $239K |
| ◆ insider | 2026-02-09 | Piazza Nicholas J. Other | SELL | $1.1M |
| ◆ insider | 2026-02-05 | BLINN MARK A Director | SELL | $213K |
| ◆ insider | 2026-02-05 | BLINN MARK A Director | SELL | $226K |
| ◆ insider | 2025-12-03 | Karsanbhai Surendralal Lanca C-suite | SELL | $966K |
| Congress | 2025-11-05 | Richard Dean McCormick | BUY | $1K–$15K |
| Congress | 2025-09-23 | Valerie Hoyle | SELL | $1K–$15K |
| Congress | 2025-07-14 | Valerie Hoyle | BUY | $1K–$15K |
| Congress | 2025-07-11 | Ritchie John Torres | SELL | $1K–$15K |
| ◆ insider | 2025-05-12 | Train Michael H. C-suite | SELL | $3.4M |
| ◆ insider | 2025-05-08 | Karsanbhai Surendralal Lanca C-suite | SELL | $1.9M |
| Congress | 2025-04-08 | Rob Bresnahan | SELL | $1K–$15K |
| Congress | 2025-03-12 | Lisa McClain | SELL | $1K–$15K |
| Congress | 2025-03-03 | Bruce Westerman | BUY | $1K–$15K |
| Congress | 2025-02-25 | Rob Bresnahan | BUY | $1K–$15K |
| ◆ insider | 2025-02-12 | LEVATICH MATTHEW S Director | SELL | $233K |
FAQ Common questions
How much has Congress traded EMR?
45 disclosed buys and 29 sells of EMR (Emerson Electric Co.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade EMR?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.